Incidence, risk factors, and outcomes of patients who develop mucosal barrier injury–laboratory confirmed bloodstream infections in the first 100 days after allogeneic …
Importance Patients undergoing hematopoietic stem cell transplant (HSCT) are at risk for
bloodstream infection (BSI) secondary to translocation of bacteria through the injured
mucosa, termedmucosal barrier injury–laboratory confirmed bloodstream infection (MBI-
LCBI), in addition to BSI secondary to indwelling catheters and infection at other sites (BSI-
other). Objective To determine the incidence, timing, risk factors, and outcomes of patients
who develop MBI-LCBI in the first 100 days after HSCT. Design, Setting, and Participants A …
bloodstream infection (BSI) secondary to translocation of bacteria through the injured
mucosa, termedmucosal barrier injury–laboratory confirmed bloodstream infection (MBI-
LCBI), in addition to BSI secondary to indwelling catheters and infection at other sites (BSI-
other). Objective To determine the incidence, timing, risk factors, and outcomes of patients
who develop MBI-LCBI in the first 100 days after HSCT. Design, Setting, and Participants A …